PCSK9
Sort by:
ACC 2024 Insights
ACC 2024 Insights: Is Bampedoic Acid a Useful Alternative to PCSK9 Inhibitors?
FEATURING
Stephen Nicholls
- 9 views
- April 26, 2024
ACC 2024 Insights
ACC 2024 Insights: What Should I Do About an Elevated Lp(a) Based on Current Evidence and Available Treatments?
FEATURING
Raul Santos
- 750 views
- April 16, 2024
- 5
ACC 2024 Insights
ACC 2024 Insights: Measure Lp(a) in All Patients Once: One & Done!
FEATURING
Samia Mora
- 1,410 views
- April 11, 2024
- 20
MUSC Cardiology
Big Questions About Lipoprotein “Little” (a)
FEATURING
Ashley Arana Waring
- 997 views
- March 29, 2024
- 14
MUSC Cardiology
Evolving Therapies in Dyslipidemia, ASCVD Risk Reduction: Putting It All Together in High-Risk Patients
FEATURING
Pamela B. Morris
- 386 views
- March 29, 2024
- 6
MUSC Cardiology
Complex Case Discussion: Familial Hypercholesterolemia
FEATURING
Kellie Mclain,
Pamela B. Morris,
Ashley Arana Waring,
Marc-André Cornier,
Matthew Budoff,
Jan Basile
- 8 views
- March 29, 2024
MUSC Cardiology
Complex Case Discussion: Dyslipidemia Management
FEATURING
Kellie Mclain,
Pamela B. Morris,
Ashley Arana Waring,
Marc-André Cornier,
Matthew Budoff,
Jan Basile
- 23 views
- March 29, 2024
MUSC Cardiology
The Top Clinical Trials in Preventive Cardiology: VERVE 101
FEATURING
Martha Gulati
- 6 views
- March 29, 2024
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Defining and Treating Dyslipidemia
FEATURING
Michael J. Wilkinson
- 868 views
- March 6, 2024
- 7
Penn Medicine Heart and Vascular Center
Lipoprotein(a) and Cardiovascular Risks: New Insights
FEATURING
Vera Bittner
- 1,941 views
- December 19, 2023
- 10
15th Annual Orange County Symposium for Cardiovascular Disease Prevention
LDL-C: Earlier and Lower Is Better and Safer?
FEATURING
Paul Rosenblit
- 3,435 views
- November 27, 2023
- 17
Jefferson Health
Advanced Testing and Lifestyle Modifications in the Cardiac Patient: An Integrative Approach
FEATURING
Alaina King
- 30 views
- November 24, 2023
Penn Medicine Heart and Vascular Center
Treatments for CV Risk Reduction: Clinical Case Discussion
- 84 views
- November 21, 2023
- 1
Penn Medicine Heart and Vascular Center
Who Is Appropriate for PCSK-9 Inhibitors, Including Inclisiran?
FEATURING
Archna Bajaj
- 363 views
- November 21, 2023
- 1
Integrity Continuing Education
Cross-Setting Strategies for Improved Management of Homozygous Hypercholesterolemia in Cardiology Settings
FEATURING
Mary Mcgowan
- 31 views
- November 3, 2023
Michael Albosta
Inclisiran for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease
- 1,061 views
- October 11, 2023
- 6
The Texas Heart Institute
Non-Statin Therapies, Expert ACC Consensus
FEATURING
Christie Ballantyne
- 1,259 views
- September 7, 2023
- 10
Complex Coronary Cases
Updated Lipid Guidelines and Therapy
FEATURING
Icilma Fergus
- 6,195 views
- September 5, 2023
- 42
Complex Coronary Cases
LIVE Round Table: Panel Discussion on Lipid Management
FEATURING
Roxana Mehran
- 93 views
- August 31, 2023
- 2
Complex Coronary Cases
Lp(a): The New Kid on the Block
FEATURING
Pam Taub
- 2,553 views
- August 31, 2023
- 20
Complex Coronary Cases
LDL-c Reduction: How Low Can You Go?
FEATURING
Philippe Gabriel Steg
- 1,315 views
- August 31, 2023
- 13
Complex Coronary Cases
Eliminating Coronary Artery Disease
FEATURING
Marc Sabatine
- 1,164 views
- August 31, 2023
- 10
Canadian Collaborative Research Network
Approaching a Decade of PCSK9 Inhibition: Effects on CV Mortality
FEATURING
Milan Gupta
- 390 views
- July 26, 2023
- 2